These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24677792)

  • 1. Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system.
    Barile E; Wang S; Das SK; Noberini R; Dahl R; Stebbins JL; Pasquale EB; Fisher PB; Pellecchia M
    ChemMedChem; 2014 Jul; 9(7):1403-12. PubMed ID: 24677792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells.
    Wang S; Placzek WJ; Stebbins JL; Mitra S; Noberini R; Koolpe M; Zhang Z; Dahl R; Pasquale EB; Pellecchia M
    J Med Chem; 2012 Mar; 55(5):2427-36. PubMed ID: 22329578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
    Wu B; Wang S; De SK; Barile E; Quinn BA; Zharkikh I; Purves A; Stebbins JL; Oshima RG; Fisher PB; Pellecchia M
    Chem Biol; 2015 Jul; 22(7):876-887. PubMed ID: 26165155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of paclitaxel to EphA2-expressing cancer cells.
    Wang S; Noberini R; Stebbins JL; Das S; Zhang Z; Wu B; Mitra S; Billet S; Fernandez A; Bhowmick NA; Kitada S; Pasquale EB; Fisher PB; Pellecchia M
    Clin Cancer Res; 2013 Jan; 19(1):128-37. PubMed ID: 23155185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
    Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
    Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2.
    Baggio C; Udompholkul P; Gambini L; Pellecchia M
    J Med Chem; 2022 Nov; 65(22):15443-15456. PubMed ID: 36331527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming Cancer Stem-like Cells with Nanoforskolin Enhances the Efficacy of Paclitaxel in Targeting Breast Cancer.
    Singh D; Singh P; Pradhan A; Srivastava R; Sahoo SK
    ACS Appl Bio Mater; 2021 Apr; 4(4):3670-3685. PubMed ID: 35014452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.
    Patel AR; Chougule M; Singh M
    Pharm Res; 2014 Oct; 31(10):2796-809. PubMed ID: 24867421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational and laboratory approach for the investigation of interactions of peptide conjugated natural terpenes with EpHA2 receptor.
    Goncalves BG; Banerjee IA
    J Mol Model; 2023 Jun; 29(7):204. PubMed ID: 37291458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
    Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
    Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell.
    Gambini L; Salem AF; Udompholkul P; Tan XF; Baggio C; Shah N; Aronson A; Song J; Pellecchia M
    ACS Chem Biol; 2018 Sep; 13(9):2633-2644. PubMed ID: 30110533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers.
    Guo Z; He B; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Int J Pharm; 2015 Sep; 493(1-2):380-9. PubMed ID: 26004003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
    Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
    Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.
    Salem AF; Wang S; Billet S; Chen JF; Udompholkul P; Gambini L; Baggio C; Tseng HR; Posadas EM; Bhowmick NA; Pellecchia M
    J Med Chem; 2018 Mar; 61(5):2052-2061. PubMed ID: 29470068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.
    Oner E; Kotmakci M; Baird AM; Gray SG; Debelec Butuner B; Bozkurt E; Kantarci AG; Finn SP
    J Nanobiotechnology; 2021 Mar; 19(1):71. PubMed ID: 33685469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
    Liu Z; Tao Z; Zhang Q; Wan S; Zhang F; Zhang Y; Wu G; Wang J
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):687-695. PubMed ID: 29392452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
    Pilkington-Miksa M; Arosio D; Battistini L; Belvisi L; De Matteo M; Vasile F; Burreddu P; Carta P; Rassu G; Perego P; Carenini N; Zunino F; De Cesare M; Castiglioni V; Scanziani E; Scolastico C; Casiraghi G; Zanardi F; Manzoni L
    Bioconjug Chem; 2012 Aug; 23(8):1610-22. PubMed ID: 22770429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting EphA2-Sam and Its Interactome: Design and Evaluation of Helical Peptides Enriched in Charged Residues.
    Mercurio FA; Marasco D; Di Natale C; Pirone L; Costantini S; Pedone EM; Leone M
    Chembiochem; 2016 Nov; 17(22):2179-2188. PubMed ID: 27763725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ephrin mimetic peptide that selectively targets the EphA2 receptor.
    Koolpe M; Dail M; Pasquale EB
    J Biol Chem; 2002 Dec; 277(49):46974-9. PubMed ID: 12351647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.
    Udompholkul P; Baggio C; Gambini L; Sun Y; Zhao M; Hoffman RM; Pellecchia M
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.